Asunto(s)
Femenino , Humanos , Masculino , Persona de Mediana Edad , Carcinoma de Células Renales/genética , Neoplasias Renales/genética , Metaloproteinasa 1 de la Matriz/genética , Regiones Promotoras Genéticas , Polimorfismo de Nucleótido Simple/genética , Estudios de Casos y Controles , Carcinoma de Células Renales/enzimología , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Genotipo , Neoplasias Renales/enzimología , Polimorfismo de Longitud del Fragmento de RestricciónRESUMEN
OBJECTIVE: Investigate the possible association of insertion/deletion (2G/G) polymorphism at nucleotide -1607 of the MMP-1 promoter with the development and progression of renal cancer MATERIALS AND METHODS: In this study, we genotyped 217 individuals, 99 patients with renal cell carcinoma (RCC) and 118 controls without cancer. DNA specimens were extracted from epithelial buccal cells and paraffin-embedded tissue of RCC patients and from epithelial buccal cells and blood cells of healthy controls RESULTS: The difference in frequency of 2G/2G genotype between controls (22.9 percent) and RCC patients (28.6 percent) was not statistically significant (p = 0.461). We also did not find correlation between 2G/2G and histological type of RCC. The comparison of genotype distribution and frequency of 2G allele in different populations showed a strong variability of 2G allele frequency among the different ethnic groups. This fact may influence on the collaboration of this 2G allele in RCC or others diseases CONCLUSION: Our data suggest that the matrix metalloproteinase-1 (MMP-1) promoter polymorphism may not play a significant role in renal cell carcinoma patients in Brazil.